Emerging Players in the Taiwan Donepezil Market | Top Companies & Insights 2026

Emerging Players in the Taiwan Donepezil Market

The Taiwan Donepezil Market is led by leading pharmaceutical manufacturers, with a focus on the health of the central nervous system (CNS), and providing key acetylcholinesterase inhibitors for the management of cognitive impairment and Alzheimer's dementia. The key players in the market include Bora Pharmaceuticals, Lotus Pharmaceutical, ScinoPharm Taiwan, TTY Biopharm, Yung Shin Pharmaceutical, Standard Chem & Pharm, China Chemical & Pharmaceutical, Synmosa Biopharma, Orient EuroPharma and Adimmune Corporation.

Taiwan Donepezil Market Overview

According to 6wresearch, the Taiwan Donepezil market is expected to grow in accordance with industry trends, due to the fast-growing aging population and increasing focus on geriatric mental health services under the National Health Insurance (NHI) program. Donepezil is considered a first-line pharmacological treatment for the improvement of cognitive function, memory retention and stability of behaviour for Alzheimer-type dementia.

The market is being fuelled by the development of local healthcare infrastructure, emphasizing the importance of neurodegenerative care, with specialized clinics and hospitals incorporating Donepezil into routine long-term care programs. Increasingly, domestic production capacity is directed towards high bioavailability oral formulations and novel delivery systems, to ensure ready availability of advanced therapeutic options.

Competitive Landscape

The competitive landscape of the Taiwan Donepezil industry consists of domestic pharmaceutical giants and international collaborations. To ensure that compounds that modulate neurotransmission are consistently effective, leading companies are working hard to achieve strict quality control. In addition, there is an increasing interest in improving patient compliance with the development of advanced formulations, and transdermal technologies to minimize gastrointestinal side effects.

Below is a list of leading players operating in the Taiwan Donepezil Market:

1. Bora Pharmaceuticals Co., Ltd.

Bora leverages its global CDMO expertise and strong local distribution networks to provide high-quality CNS medications, emphasizing operational excellence in geriatric care.

2. Lotus Pharmaceutical Co., Ltd.

Lotus utilizes its international R&D capabilities and strategic global partnerships to introduce innovative Donepezil-based therapies to the domestic market.

3. ScinoPharm Taiwan, Ltd.

ScinoPharm focuses on the synthesis of high-purity active pharmaceutical ingredients and advanced drug products, supporting the local neurodegenerative supply chain.

4. TTY Biopharm Company Limited

TTY Biopharm specializes in complex drug delivery systems and maintains a focus on life-critical therapeutic areas, including CNS and oncology.

5. Yung Shin Pharmaceutical Ind. Co., Ltd.

Yung Shin provides a wide range of essential neuro-active medications, ensuring broad accessibility across Taiwan's regional clinics and hospitals.

6. Standard Chem & Pharm Co., Ltd.

Standard Chem & Pharm utilizes its long-standing manufacturing heritage to produce reliable and affordable Donepezil formulations for long-term cognitive care.

7. China Chemical & Pharmaceutical Co., Ltd. (CCPC)

CCPC focuses on consistent, high-standard pharmaceutical manufacturing, playing a key role in the supply of cognitive enhancers for the geriatric population.

8. Synmosa Biopharma Corporation

Synmosa maintains a robust portfolio of specialty drugs, contributing to the neurological health sector through quality-assured, patient-centric formulations.

9. Orient EuroPharma Co., Ltd. (OEP)

OEP serves as a key supplier for specialized dementia care, focusing on providing high-efficacy treatments that meet international safety standards.

10. Adimmune Corporation

Adimmune utilizes its advanced manufacturing platforms to support the healthcare sector, ensuring the stable supply of essential CNS therapeutics for aging patients.

Emerging Players in the Taiwan Donepezil Market: FAQs